{"schema_version":"secwatch.filing_event.v1","accession":"0001852244-25-000020","form_type":"8-K","ticker":"GXO","cik":"0001852244","company_name":"GXO Logistics, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.157549+00:00","generated_at":"2026-05-22T09:03:10.898274+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"GXO Q1 revenue up 21% to $3B; net loss widens to $95M; reaffirms FY guidance","bullets":["Revenue $3.0B (+21% YoY), organic growth 3%; net loss $95M vs $36M loss YoY; diluted EPS -$0.81.","Adjusted EBITDA $163M vs $154M; adjusted diluted EPS $0.29 vs $0.45.","Signed $228M new business wins; sales pipeline (ex-Wincanton) at 3-year high of $2.5B.","Landmark NHS Supply Chain contract: largest-ever, total lifetime value ~$2.5B.","Repurchased 2.8M shares; reaffirmed FY2025 organic revenue and adjusted EBITDA guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001852244-25-000020","json":"https://secwatch.observer/filing/0001852244-25-000020.json","markdown":"https://secwatch.observer/filing/0001852244-25-000020.md","text":"https://secwatch.observer/filing/0001852244-25-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1852244/000185224425000020/0001852244-25-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1852244/000185224425000020/gxo-20250507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T09:03:10.898274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}